1. ALLA AKTIER
  2. NYHETER
  3. STILLE

Stille

Nyheter Stille Nyheter alla bolag

Stille AB: Interim Report Q1 2025

MAR

Stille AB (publ) today presents the report for the first quarter 2025.

Revenue amounted to 129.3 MSEK (139.7) impacted by temporary delivery restrictions and the phase-out of non-strategic products.

“Stille starts 2025 with a quarter marked by temporary challenges.” says Torbjörn Sköld but also points out,“Order intake
remained strong, in line with financial targets, providing good conditions for recovery and growth during the rest of the year”

The gross profit amounted to 51.1 percent (48.6) and EBIT before one-time costs amounted to 17.9 MSEK (27.0).

” In June 2025, I will step down as CEO. The Board is currently conducting a thorough recruitment process to ensure continuity of leadership and maintain the company’s strategic direction. I leave my role with full confidence in the Stille team, the company’s strategy and the future”, concludes Stille’s CEO.

MSEKJAN-MAR
2025		JAN-MAR
2024		APR-MAR
2024/2025		JAN-DEC
2024
Net sales129.3 139.7 559.6 569.9 
Gross profit, %51.1 48.6 52.5 51.9 
EBITDA before non-recurring items25.2 33.7 134.0 142.4 
EBITDA before non-recurring items, %19.5 24.1 23.9 25.0 
EBITDA25.2 17.0 106.2 98.0 
EBITDA, %19.5 12.2 19.0 17.2 
EBIT before non-recurring items17.9 27.0 105.8 114.9 
EBIT before non-recurring items, %13.8 19.3 18.9 20.2 
EBIT17.9 10.3 78.1 70.5 
EBIT, %13.8 7.4 13.9 12.4 

Torshälla, April 24th, 2025.

This information is information that Stille is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2025-04-24 08:00 CEST.

Contact Details
Torbjörn Sköld
CEO & President
+46 (0)70 316 63 91 | torbjorn.skold@stille.se

About Us
Stille AB (publ) develops, manufactures and markets medical devices for surgeons across the world. Stille was founded in 1841 and is one of the world’s oldest medical device companies. Stille’s main business areas are surgical instruments and c-arm tables. Stille’s surgical instruments are mostly used during different kinds of open surgery. During minimal invasive procedures. the c-arm tables imagiQ2 and Medstone are key products. The company has a strong brand and products of a renowned high-quality. The share is listed on First North Growth Market under the acronym “STIL” with Eminova AB as Certified Adviser, Eminova Fondkommission AB, + 46 8 684 211 10, adviser@eminova.se. For more information, visit www.stille.se.

Attachments
Interim Report Q1 2025

Datum 2025-04-24, kl 08:00
Källa MFN
Bifogade filer
Interim Report Q1 2025
Affiliate
SAVR är investeringsplattformen som utmanar branschen och gör det både enklare och roligare att investera. Betala aldrig för mycket! Alla aktier och ETF:er från 1 kr, och få upp till 50 % rabatt på alla fonder. Automatiskt courtage och samma enkla prismodell på alla marknader.
Investeringar i värdepapper och fonder innebär alltid en risk och det är inte säkert att du får tillbaka det investerade kapitalet